SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-090040
Filing Date
2022-08-12
Accepted
2022-08-12 16:05:44
Documents
2
Period of Report
2022-08-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2222999-6_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2222999-6_3seq1.xml 3 2222
2 EXHIBIT 24.1 tm2222999d6_ex24-1.htm EX-24.1 7354
  Complete submission text file 0001104659-22-090040.txt   11084
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 380 LACKAWANNA PLACE SOUTH ORANGE NJ 07079
Business Address
Lask Alisa (Reporting) CIK: 0001767593 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38709 | Film No.: 221160022